Vermont House votes to legalize marijuana

The Vermont House passed a bill Thursday night to legalize recreational possession of marijuana just hours after Attorney General Jeff Sessions rescinded a Department of Justice policy on legal marijuana.

Aurora Cannabis Announces $200 Million Bought Deal Financing

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has entered into an agreement with a syndicate of underwriters, led by Canaccord Genuity Corp., pursuant to which Canaccord Genuity has agreed to purchase, on a bought deal basis, 200,000 convertible debentures, at a price of $1,000 per Initial Convertible Debenture, for gross proceeds of $200 million.

ABcann Adds Big Alcohol Expertise with New Chief Marketing Officer

ABCANN GLOBAL CORPORATION (TSX-V:ABCN) is pleased to announce the appointment of Sung Kang as the Company's Chief Marketing Officer (CMO). Mr. Kang, who will assume the position effective January 8, 2018, was formerly the Head of Marketing for the Mike’s Beverage Company, Canada’s leading ready-to-drink and cider business, owned by Labatt Breweries of Canada.

INMED CLOSES OVER-SUBSCRIBED C$9.4 MILLION FINANCING

InMed Pharmaceuticals, Inc. (CSE:IN; OTCQB: IMLFF), has closed its previously announced non-brokered private placement for gross proceeds of C$9.4 Million through the issuance of 13,428,571 units, with terms as previously announced on December 18, 2017.

Liberty Health Sciences Inc. Announces Proposed Acquisition of a 387 Acre Parcel of Land in Gainesville Including 200,000 Square Feet of Greenhouse and Processing Facilities

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has entered into a binding term sheet to acquire all of the issued and outstanding shares of 242 Cannabis Canada Ltd., whose wholly-owned subsidiary 242 Cannabis, LLC, has agreed to purchase a 387 acre parcel of land in Gainesville, Florida.

Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale

Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited investor under which the Investor has agreed, subject to certain customary conditions, to purchase 3,000,000 units of the Company at a price of $5.00 per Unit for total gross proceeds of $15,000,000.